Medicare Diabetes Prevention telehealth program expected to continue through 2023
By
John Roszkowski
May 02, 2023
The Medicare Diabetes Prevention Program’s telehealth capabilities will not cease when the public health emergency is allowed to sunset in nine days, allowing program providers more time to resume in-person...
New access to less costly, specialized dementia CT scan diagnostics found
By
Aaron Dorman
Oct 24, 2023
A new technique uses AI and CT scans to help diagnose brain disorders, including dementia, according to a study of more than 1,000 seniors.
Tech can aid senior living and care staff, but cost and privacy still big concerns: expert weighs in
By
Aaron Dorman
Sep 07, 2023
Some challenges related to properly staffing skilled nursing facilities can be met by using tools like patient monitoring, an expert on health technology notes.
Caregivers, seniors with Alzheimer’s to benefit from ‘Rippl’ effect, access to 24/7 helpline
By
Aaron Dorman
Apr 09, 2024
A new dementia care platform will get telehealth to more seniors, and their caregivers, including access to a 24/7 helpline.
FDA clears non-invasive ventilation device that accesses mouth without mask removal
By
Aaron Dorman
Jul 24, 2023
An NIV device that allows for access to the patient’s mouth and communication was approved for clearance by the FDA.
CMS officially removes one-time restriction for Alzheimer’s PET scan coverage
By
Aaron Dorman
Oct 17, 2023
Seniors covered by Medicare will now have expanded access to Alzheimer’s diagnostic PET scans after the CMS removed one-time restrictions.
Senior living in 2024: Volatility ahead argues for rethinking risk strategies
By
Gerald Stoll
Jordan Parnell
Dec 14, 2023
The pressures on the senior living sector only abated marginally in 2023, as operators tried to maintain their balance in a precarious business and economic environment. And any significant reversal in...
Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
Creators of a new AI tool for healthcare decisions cite superior training methods, net $13 million in...
By
Aaron Dorman
Aug 04, 2023
An AI startup received $13 million for their model which trains on medical data rather than text.
Brain imaging company teases tech that will analyze side effects of new dementia drugs
By
Aaron Dorman
Nov 28, 2023
AI-enabled brain imaging technology will be launched next year to evaluate the side effects of new Alzheimer’s and dementia drugs.